Germany Nuclear Imaging Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 504.08 Million |
| Market Size (2029) | USD 614.17 Million |
| CAGR (2024 - 2029) | 4.03 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Germany Nuclear Imaging Market Analysis
The Germany Nuclear Imaging Market size is estimated at USD 504.08 million in 2024, and is expected to reach USD 614.17 million by 2029, growing at a CAGR of 4.03% during the forecast period (2024-2029).
COVID-19 has severely impacted the market studied during the year 2020 owing to quick actions taken by the government for postponing non-essential diagnostic procedures in hospitals. Besides the negative impact of COVID-19, it has created opportunities for players in the nuclear imaging field to establish their presence by launching new products or progressing clinical studies in this field. For instance, in April 2021, Isotopen Technologien Munchen, Germany received a USD 109 million loan to push forward the study of Lutetium-177 which is expected to emit a low amount of radioactive energy as compared to other radiopharmaceuticals. Owing to such activities in the country, the nuclear imaging market is getting the benefits and is expected to witness strong growth in the coming years.
Factors such as the increasing burden of chronic diseases and the presence of key companies in the country are responsible for the market growth. Furthermore, many companies entered into a partnership to provide the radiopharmaceutical industry with a unique service solution for theranostic drug development. For instance, in July 2021, Oncodesign, Covalab, CheMatech, and ABX-CRO entered into a partnership to launch DRIVE-MRT (Molecular Radiotherapy) solution, which will have all technologies related to the validation of targets, the generation and optimization of vectors and the radiochemistry and PET / SPECT imaging techniques. These partnerships are streghthning the market of nuclear imaging in Germany.
Hence, due to the above-mentioned factors, the market for nuclear imaging is growing rapidly in Germany.
Germany Nuclear Imaging Market Trends
This section covers the major market trends shaping the Germany Nuclear Imaging Market according to our research experts:
Oncology is Expected to Witness Significant Share in Application Segment
Cancer is one of the leading causes of morbidity and mortality in Germany. The burden of cancer is rising every year as more people are being diagnosed with cancer in the country.
According to the 2020 Globocan report, there were 274,364 new cancer cases diagnosed and 86,684 deaths due to cancer in 2020. Adding to that, the number of prevalent cases (5 years) of cancer was 2,188,176. The most common cancers in Germany are lung cancer, prostate cancer, bladder cancer, colorectum cancer, and skin cancer. Similarly, as per the Robert Koch Institute, 2021 data, approximately 16,500 patients develop kidney cancer in Germany each year. The rising cases of cancer in the country are augmenting the demand for better diagnosis in the early stages of the disease. As nuclear imaging is one of the most reliable diagnostic methods for cancers, it is believed that the market for nuclear imaging will witness strong growth over the forecast period.
Furthermore, data published by the University Hospital of Würzburg, Germany in 2021 suggests that FDG PET/CT imaging had a high negative predictive value in detecting cervical lymph node metastasis in patients with newly diagnosed, treatment-naive Squamous Cell carcinoma of the oral cavity. The scans can also detect metastasis proving the multiple uses of these tests. Hence, the effectiveness of PET CT scan in the diagnosis of certain cancers is augmenting its demand across the country.
Germany Nuclear Imaging Industry Overview
The nuclear imaging market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, among others, hold the substantial share in the market.
Germany Nuclear Imaging Market Leaders
-
Bracco Imaging Spa
-
Siemens AG
-
Koninklijke Philips N.V.
-
GE Healthcare
-
Canon Medical Systems
*Disclaimer: Major Players sorted in no particular order
Germany Nuclear Imaging Market News
- In July 2021, EQT Infrastructure, advised by BGM Associates, has signed the acquisition of both Meine Radiologie and Blikk to form the leading outpatient radiology and radiotherapy provider in Germany.
- In January 2021, IRE ELiT and ROTOP Pharmaka, two innovative radiopharmaceutical companies focused on diagnostics and therapeutics announced that they have entered into an exclusive commercial agreement for the distribution of Galli Ad (the 68Ge/68Ga generator from IRE ELiT) in Germany. This collaboration increases the presence of Galli Ad generators in Germany, representing the leading market in Europe for Gallium-68 development.
Germany Nuclear Imaging Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Cancer and Cardiac Disorders
- 4.2.2 Technological Advancements in Nuclear Imaging
-
4.3 Market Restraints
- 4.3.1 Stringent Regulations
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Equipment
- 5.1.2 Diagnostic Radioisotope
- 5.1.2.1 SPECT Radioisotopes
- 5.1.2.2 PET Radioisotopes
-
5.2 By Application
- 5.2.1 SPECT Applications
- 5.2.1.1 Cardiology
- 5.2.1.2 Neurology
- 5.2.1.3 Thyroid
- 5.2.1.4 Other SPECT Applications
- 5.2.2 PET Applications
- 5.2.2.1 Oncology
- 5.2.2.2 Cardiology
- 5.2.2.3 Neurology
- 5.2.2.4 Other PET Applications
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Canon Medical Systems Corporation
- 6.1.2 Fujifilm Holdings Corporation
- 6.1.3 GE Healthcare
- 6.1.4 Koninklijke Philips NV
- 6.1.5 Siemens Healthineers
- 6.1.6 Curium
- 6.1.7 Medison Ltd
- 6.1.8 Bracco Group
- 6.1.9 NOVARTIS AG (ADVANCED ACCELERATOR APPLICATIONS)
- 6.1.10 Bayer AG
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityGermany Nuclear Imaging Industry Segmentation
Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. Germany's Nuclear Imaging market is segmented by Product (Equipment, Diagnostic Radioisotopes), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments.
| By Product | Equipment | |
| Diagnostic Radioisotope | SPECT Radioisotopes | |
| PET Radioisotopes | ||
| By Application | SPECT Applications | Cardiology |
| Neurology | ||
| Thyroid | ||
| Other SPECT Applications | ||
| By Application | PET Applications | Oncology |
| Cardiology | ||
| Neurology | ||
| Other PET Applications |
Germany Nuclear Imaging Market Research FAQs
How big is the Germany Nuclear Imaging Market?
The Germany Nuclear Imaging Market size is expected to reach USD 504.08 million in 2024 and grow at a CAGR of 4.03% to reach USD 614.17 million by 2029.
What is the current Germany Nuclear Imaging Market size?
In 2024, the Germany Nuclear Imaging Market size is expected to reach USD 504.08 million.
Who are the key players in Germany Nuclear Imaging Market?
Bracco Imaging Spa, Siemens AG, Koninklijke Philips N.V., GE Healthcare and Canon Medical Systems are the major companies operating in the Germany Nuclear Imaging Market.
What years does this Germany Nuclear Imaging Market cover, and what was the market size in 2023?
In 2023, the Germany Nuclear Imaging Market size was estimated at USD 484.55 million. The report covers the Germany Nuclear Imaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Germany Nuclear Imaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Germany Nuclear Imaging Industry Report
Statistics for the 2024 Germany Nuclear Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Germany Nuclear Imaging analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
